BPG is committed to discovery and dissemination of knowledge
Evidence-Based Medicine
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Mar 15, 2026; 18(3): 117278
Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.117278
Figure 2
Figure 2 Cost-effectiveness plot. Undominated, positive incremental cost-effective ratios are regarded as undominated. EDS: Endoscopic screening; SCS: Sponge cytology screening; QALY: Quality-adjusted life year.


Write to the Help Desk